9.79
price down icon0.71%   -0.07
pre-market  Pre-mercato:  9.62   -0.17   -1.74%
loading

Neumora Therapeutics Inc Azioni (NMRA) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
47.31%
60.07
114.00 56.86 - -
Operating Income/Loss
47.31%
-60.07
-114.00 -56.86 - -
Nonoperating Income/Loss
14.63%
6.353
5.542 3.837 - -
Income/Loss From Continuing Operations Before Tax
50.47%
-53.72
-108.46 -53.03 -38.54 -35.62
Income/Loss From Continuing Operations After Tax
50.59%
-53.72
-108.73 -53.03 -38.54 -35.62
Net Income/Loss
50.59%
-53.72
-108.73 -53.03 -38.54 -35.62
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
433.72%
157.94
29.59 46.69 - -
Diluted Average Shares
433.72%
157.94
29.59 46.69 - -
Basic Earnings Per Share
750.00%
-0.34
-0.04 -1.14 - -
Diluted Earnings Per Share
750.00%
-0.34
-0.04 -1.14 - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$71.05
price up icon 0.69%
$18.62
price down icon 6.90%
$36.94
price down icon 0.94%
$364.33
price up icon 1.00%
$194.26
price up icon 3.46%
$102.14
price down icon 4.00%
Capitalizzazione:     |  Volume (24 ore):